BOSTON (AP) _ Akcea Therapeutics Inc. (AKCA) on Tuesday reported a first-quarter loss of $42.9 million, after reporting a profit in the same period a year earlier.
The Boston-based company said it had a loss of 42 cents per share.
The biopharmaceutical company posted revenue of $16.1 million in the period.
Akcea Therapeutics shares have fallen 2% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $16.57, a decrease of 37% in the last 12 months.